Decellularized cardiac ECM: A tissue-specific bioactive platform for drug release and cell delivery.
The interactions between matrix composition, its capacity to protect therapeutic factors and enhance cell retention, and therapeutic release profiles that collectively regulate cardiac tissue repair outcomes are emphasized and emerging clinical applications and regulatory challenges for next-generation dcECM-based therapeutics are highlighted.